arrow
Back
P

Peter van der Meer

university of groningen

70H-index
287Paper Count
2.3WCitation Count
Published Papers 183
Publication Date
Elevated 5-oxoproline levels and adverse outcomes in heart failure: Association with renal cortical OPLAH loss in a multi-comorbidity model
err2026-08-17
err0
errOAAI
errAntonio Esquivel-Gaytan; Ali A. Al-Mubarak; Oana Sorop; Daphne Merkus; Adriaan A. Voors; Herman H.W. Silljé; Dirk J. Duncker; Peter van der Meer; Nils Bomer
errShare
errSave
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial
err2026-06-26
err0
errOAAI
errPeter C. Kahr; Fabian aus dem Siepen; Olivier Lairez; Erwan Donal; Thibaud Damy; Arnt V. Kristen; Cristina C. Quarta; Michele F. Mercuri; Sarah Keppner-Witter; Eva Herrmann-Keiner; Mia Tichy; Aubin Michalon; Jan Grimm; Roger M. Nitsch; Christoph Hock; Pablo Garcia-Pavia; Peter van der Meer
errShare
errSave
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
err2026-05-10
err0
errOAAI
errD. J. van Veldhuisen; M. Rienstra; A. Mosterd; M. Alings; A. A. Voors; K. Damman; A. D. I. van Asselt; M. L. Bouvy; J. Schaap; E. E. van der Wall; H. J. G. M. Crijns; D. J. Touw; P. A. M. Hoogslag; J. E. C. van de Swaluw; R. J. Schuurman; A. van der Sluis; O. Bondarenko; T. J. Römer; T. Oosterhof; G. L. Bartels; S. Koudstaal; P. A. Dijkmans; G. C. M. Linssen; I. Aksoy; H. G. R. Dorman; A. Schut; M. E. W. Hemels; R. G. Tieleman; D. J. A. Lok; I. C. D. Westendorp; M. A. T. Vijver; G. H. D. Voordes; A. H. de Vos; E. L. Maas-Soer; D. Postmus; G. Lunter; J. G. P. Tijssen; P. van der Meer
errShare
errSave
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
err2026-05-10
err0
errOAAI
errPeter van der Meer; Dirk J van Veldhuisen; Geert H D Voordes; Jan Tijssen; Marco Alings; M L Bouvy; Henk P Swart; H Jaco Houtgraaf; H G Reinhart Dorman; Michiel Rienstra; Kevin Damman; Arend Mosterd
errShare
errSave
Preferences regarding preconceptional and genetic counselling and pregnancy check-ups among women with the PLN p. (Arg14del) variant
err2026-02-01
err1
errOAAI
errHogenhout, Sietske A.; Prins, Jelmer R.; van Spaendonck-Zwarts, Karin Y.; Cox, Moniek G. P. J.; Gordijn, Sanne J.; van der Meer, Peter; Abheiden, Carolien N. H.
errShare
errSave
Tolerability of continued treatment with ATTR depleter ALXN2220 in the open-label extension of Phase 1 study NI006-101
err2025-11-05
err0
PREAI
errO Lairez; F Aus Dem Siepen; T Damy; E Donal; A V Kristen; P Van Der Meer; C Quarta; M F Mercuri; R M Nitsch; J Grimm; M Tichy; A Michalon; C Hock; P C Kahr; P Garcia-Pavia
errShare
errSave
HELIOS-B: 12-month results from the open-label extension period of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
err2025-11-05
err0
PREAI
errP Garcia-Pavia; R Witteles; C Morbach; D Delgado; H Kitaoka; M Maurer; P Van Der Meer; A Yilmaz; V Algalarrondo; S Solomon; F Cappelli; S Eraly; L Yang; J Vest; M Fontana
errShare
errSave
Outpatient loop diuretic use and the effect of natriuresis-guided diuretic therapy: A prespecified sub-analysis of the PUSH-AHF study
err2025-10-29
err0
errOAAI
errLara E.E.C. Zonneveld; Iris E. Beldhuis; Hailun Qin; Dirk J. van Veldhuisen; Jenifer E. Coster; Wybe Nieuwland; Jan A. Krikken; Peter van der Meer; Adriaan A. Voors; Kevin Damman; Jozine M. ter Maaten
errShare
errSave
RNA Therapeutics in Heart Failure
err2025-10-01
err0
errOAAI
errDeiman, Frederik E.; De Graaf, Myrthe M.; Sillje, Herman H. W.; Grote Beverborg, Niels; Bomer, Nils; van der Meer, Peter
errShare
errSave
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis from ATTRibute-CM
errJACC
IF0
err2025-09-28
err0
errOAAI
errAhmad Masri; Daniel P. Judge; Frederick L. Ruberg; Julian D. Gillmore; Justin L. Grodin; Laura Obici; Mathew S. Maurer; Marianna Fontana; Steen Hvitfeldt Poulsen; Peter van der Meer; Richard K. Cheng; Sarah A.M. Cuddy; Amrut V. Ambardekar; Kuangnan Xiong; Xiaofan Cao; Gillian Murtagh; Suresh Siddhanti; Adam Castaño; Jean-François Tamby; Jonathan C. Fox; Kevin M. Alexander; Ronald Witteles
errShare
errSave
In PLN-R14del mice, SR structure restoration, rather than calcium cycling, is the dominant effector of PLN-ASO treatment
err2025-09-01
err1
errOAAI
errSun, Liu; Eijgenraam, Tim R.; Amilon, Carl; Janzen, David; Hansson, Kenny M.; Kubli, Dieter A.; Spater, Daniela; Mullick, Adam E.; van der Meer, Peter; Teixeira, Vivian Oliveira Nunes; Sillje, Herman H. W.
errShare
errSave
Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy
err2025-05-23
err0
errOAAI
errTingen, H. S. A.; Berends, M.; Tubben, A.; van der Meer, P.; Slart, R. H. J. A.; Bijzet, J.; van der Zwaag, P. A.; Kimmich, C.; Knackstedt, C.; Muntinghe, F. L. H.; Houwerzijl, E. J.; Hazenberg, B. P. C.; Nienhuis, H. L. A.
errShare
errSave
Multigene panel analysis has limited additional value compared to transthyretin gene analysis in Dutch patients with suspected cardiac amyloidosis
err2025-03-01
err0
PREAI
errBerends, Milou; Tingen, Hendrea S. A.; Bijzet, Johan; Lemmink, Henny H.; Muntinghe, Friso L. H.; Houwerzijl, Ewout J.; van der Meer, Peter; Slart, Riemer H. J. A.; Gilbertson, Janet A.; Gans, Reinold O. B.; Hazenberg, Bouke P. C.; Nienhuis, Hans L. A.; van der Zwaag, Paul A.
errShare
errSave
Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT/CT: The I-NERVE study
err2025-02-01
err0
errOAAI
errTubben, Alwin; Prakken, Niek H. J.; V. Ivashchenko, Oleksandra; Tingen, Hendrea S. A.; Glaudemans, Andor W. J. M.; Noordzij, Walter; Nienhuis, Hans L. A.; van der Meer, Peter; Slart, Riemer H. J. A.
errShare
errSave
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials
err2024-12-18
err0
PREAI
errFoa, Alberto; Pabon, Maria A.; Braunwald, Eugene; Jering, Karola; Vaduganathan, Muthiah; Claggett, Brian L.; Kober, Lars; Lewis, Eldrin F.; Granger, Christopher B.; van Der Meer, Peter; Rouleau, Jean L.; Maggioni, Aldo P.; Mcmurray, John J. V.; Solomon, Scott D.; Pfeffer, Marc A.
errShare
errSave
Long-term safety and efficacy of antibody ALXN2220 for depletion of cardiac amyloid transthyretin: results of treatment beyond 12 months in the open-label extension of study NI006-101
err2024-10-28
err0
PREAI
errVan der Meer, P.; Lairez, O.; Donal, E.; Siepen, F. Aus Dem; Kristen, A.; Damy, T.; Quarta, C.; Mercuri, M.; Nitsch, R. M.; Grimm, J.; Rey, S.; Tichy, M.; Kahr, P. C.; Hock, C.; Garcia-Pavia, P.
errShare
errSave
The impact of exogenous ketone body suppletion on energy and pH balance in skeletal muscle during exercise in chronic heart failure patients: a prospective randomized double-blind cross-over study
err2024-10-28
err0
PREAI
errVoorrips, S. N.; Jeneson, J. A. L.; Renken, R. J.; Vijver, M. A. T.; Sibeijn-Kuiper, A. J.; Zijlstra, S. N.; Van Veldhuisen, D. J.; van der Meer, P.; Westenbrink, B. D.
errShare
errSave
Proteome profiling in patients with peripartum cardiomyopathy according to ethnicity a biomarker study on the EORP cohort
err2024-10-28
err0
PREAI
errKodogo, V.; Viljoen, C.; Chakafana, G.; Hoevelmann, J.; Jackson, A.; Al-Farhan, H.; Goland, S.; Tromp, J.; Van Der Meer, P.; Karaye, K.; Kryczka, K.; Mebazaa, A.; Bauersachs, J.; Sliwa, K.
errShare
errSave
Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry
err2024-09-02
err0
errOAAI
errvan der Meer, Peter; van Essen, Bart Johan; Viljoen, Charle; Boehm, Michael; Jackson, Alice; Hilfiker-Kleiner, Denise; Hoevelmann, Julian; Mebazaa, Alexandre; Farhan, Hasan Ali; Goland, Sorel; Ouwerkerk, Wouter; Petrie, Mark C.; Seferovic, Petar M.; Tromp, Jasper; Sliwa, Karen; Bauersachs, Johann
errShare
errSave